Treatment,Level,Total
"Cetuximab,Panitumumab(KRAS p.A146T)","Level R1",20
"Cetuximab,Panitumumab(KRAS p.G12C)","Level R1",24
,"Level R1",414
"Cetuximab,Panitumumab(KRAS p.G12D)","Level R1",92
"Cetuximab,Panitumumab(NRAS p.Q61L)","Level R1",4
"Cetuximab,Panitumumab(KRAS p.G12V)","Level R1",61
"Cetuximab,Panitumumab(KRAS p.G13D)","Level R1",47
"Cetuximab,Panitumumab(KRAS p.V14I)","Level R1",1
"Cetuximab,Panitumumab(KRAS p.Q61H)","Level R1",6
"Cetuximab,Panitumumab(NRAS p.Q61K)","Level R1",8
"Cetuximab,Panitumumab(KRAS p.G12R)","Level R1",4
"Cetuximab,Panitumumab(NRAS p.G12D)","Level R1",5
"Cetuximab,Panitumumab(KRAS p.G12A)","Level R1",14
"Cetuximab,Panitumumab(KRAS p.G12S)","Level R1",13
"Cetuximab,Panitumumab(KRAS p.K117N)","Level R1",5
"Cetuximab,Panitumumab(KRAS p.A146V)","Level R1",4
"Cetuximab,Panitumumab(KRAS p.G12F)","Level R1",1
"Cetuximab,Panitumumab(NRAS p.G12V)","Level R1",1
"Cetuximab,Panitumumab(KRAS p.G13C)","Level R1",2
"Cetuximab,Panitumumab(NRAS p.G12C)","Level R1",3
"Cetuximab,Panitumumab(KRAS p.G12A);Cetuximab,Panitumumab(NRAS p.Q61K)","Level R1",1
"Cetuximab,Panitumumab(KRAS p.D33E)","Level R1",1
"Cetuximab,Panitumumab(KRAS p.Q61R)","Level R1",2
"Cetuximab,Panitumumab(KRAS p.G12V);Cetuximab,Panitumumab(KRAS p.G12A)","Level R1",1
"Cetuximab,Panitumumab(KRAS p.G12V);Cetuximab,Panitumumab(KRAS p.D33E)","Level R1",1
,"Level 2B",635
"Crizotinib(MET Amplification)","Level 2B",8
"Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib(BRAF p.V600E)","Level 2B",44
"ado-trastuzumab emtansine,Trastuzumab+Pertuzumab,Lapatinib,Trastuzumab(ERBB2 Amplification)","Level 2B",29
"Erlotinib,Gefitinib,Afatinib(EGFR p.L861Q)","Level 2B",2
"Olaparib(BRCA2 p.D1868Vfs*5)","Level 2B",1
"Olaparib(BRCA2 p.Q1551*)","Level 2B",1
"Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib(BRAF p.V600E);Olaparib(BRCA2 p.T3085Nfs*26)","Level 2B",1
"Olaparib(BRCA2 p.S1442*)","Level 2B",1
"Olaparib(BRCA2 p.X3215_splice)","Level 2B",1
"Olaparib(BRCA2 p.F1978Lfs*26);Olaparib(BRCA2 p.K3416Nfs*11)","Level 2B",1
"Olaparib(BRCA2 p.L1545Rfs*3)","Level 2B",1
"Everolimus(TSC2 p.X325_splice)","Level 2B",1
"Everolimus(TSC1 p.X122_splice)","Level 2B",1
"Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib(BRAF p.V600E);Olaparib(BRCA2 p.K3416Nfs*11)","Level 2B",1
"Olaparib(BRCA2 p.T1359Yfs*2)","Level 2B",1
"Everolimus(TSC2 p.W896del)","Level 2B",1
"Everolimus(TSC1 p.N891Kfs*13)","Level 2B",1
"Olaparib(BRCA1 p.L1564P);Olaparib(BRCA1 p.Q210Sfs*6)","Level 2B",1
"ado-trastuzumab emtansine,Trastuzumab+Pertuzumab,Lapatinib,Trastuzumab(ERBB2 Amplification);Crizotinib(MET Amplification)","Level 2B",1
"Olaparib(BRCA2 p.L638*)","Level 2B",1
"Crizotinib(MET p.X1087_splice);Everolimus(TSC1 p.E218*);Olaparib(BRCA2 p.K3032*)","Level 2B",1
,"Level 3A",729
"LOXO-101,Entrectinib(NTRK3 LEVEL_3B)","Level 3A",1
"Panitumumab(EGFR p.S492R)","Level 3A",1
"LOXO-101(NTRK1 LEVEL_3A)","Level 3A",4
,"Level 3B",528
"Sonidegib,Vismodegib(PTCH1 p.E992*)","Level 3B",1
"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib(NRAS p.Q61L)","Level 3B",4
"AZD4547,Dovitinib(FGFR1 Amplification)","Level 3B",11
"Lapatinib+Trastuzumab,Neratinib(ERBB2 Amplification)","Level 3B",24
"alpelisib(PIK3CA p.E545K)","Level 3B",38
"alpelisib(PIK3CA p.C420R)","Level 3B",2
"Neratinib(ERBB2 p.I767M)","Level 3B",1
"alpelisib(PIK3CA p.E542K)","Level 3B",17
"alpelisib(PIK3CA p.R38C)","Level 3B",3
"Lapatinib+Trastuzumab,Neratinib(ERBB2 Amplification);Neratinib(ERBB2 p.V842I)","Level 3B",2
"alpelisib(PIK3CA p.Q546K)","Level 3B",6
"Cobimetinib,Trametinib,Selumetinib(MAP2K1 p.K57E)","Level 3B",2
"alpelisib(PIK3CA p.E365K)","Level 3B",2
"alpelisib(PIK3CA p.H1047R)","Level 3B",10
"AZD4547,Dovitinib(FGFR1 Amplification);alpelisib(PIK3CA p.E542K)","Level 3B",2
"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib(NRAS p.Q61K)","Level 3B",6
"alpelisib(PIK3CA p.N345K)","Level 3B",2
"alpelisib(PIK3CA p.E542K);alpelisib(PIK3CA p.M1043I)","Level 3B",1
"alpelisib(PIK3CA p.H1047R);alpelisib(PIK3CA p.G118D)","Level 3B",1
"alpelisib(PIK3CA p.Q546K);alpelisib(PIK3CA p.E726K)","Level 3B",1
"LEVEL_3B(NTRK3 LEVEL_3B)","Level 3B",1
"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib(NRAS p.G12D)","Level 3B",5
"alpelisib(PIK3CA p.H1047Y)","Level 3B",1
"Cobimetinib,Trametinib,Selumetinib(MAP2K1 p.K57N)","Level 3B",1
"alpelisib(PIK3CA p.H1047R);alpelisib(PIK3CA p.R93Q)","Level 3B",1
"Trametinib(BRAF p.K601E)","Level 3B",1
"Cobimetinib,Trametinib,Selumetinib(MAP2K1 p.K57T);alpelisib(PIK3CA p.*1069F)","Level 3B",1
"AZD5363(AKT1 p.E17K)","Level 3B",5
"Neratinib(ERBB2 p.S310F)","Level 3B",1
"Lapatinib+Trastuzumab,Neratinib(ERBB2 Amplification);alpelisib(PIK3CA p.G1049R)","Level 3B",1
"Sonidegib,Vismodegib(PTCH1 p.L39Cfs*41)","Level 3B",1
"alpelisib(PIK3CA p.E545K);alpelisib(PIK3CA p.E542K)","Level 3B",1
"Sorafenib,Sorafenib(ARAF p.S214P)","Level 3B",1
"Crizotinib(ALK p.R1275Q)","Level 3B",1
"Cobimetinib,Trametinib,Selumetinib(MAP2K1 p.E203K)","Level 3B",1
"alpelisib(PIK3CA p.Q546P)","Level 3B",2
"alpelisib(PIK3CA p.G1049R)","Level 3B",2
"Lapatinib+Trastuzumab,Neratinib(ERBB2 Amplification);alpelisib(PIK3CA p.H1047R)","Level 3B",1
"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib(NRAS p.G12V)","Level 3B",1
"alpelisib(PIK3CA p.N345I)","Level 3B",1
"Lapatinib+Trastuzumab,Neratinib(ERBB2 Amplification);Neratinib(ERBB2 p.V777L)","Level 3B",2
"alpelisib(PIK3CA p.M1043L)","Level 3B",1
"alpelisib(PIK3CA p.E545G)","Level 3B",2
"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib(NRAS p.G12C)","Level 3B",3
"alpelisib(PIK3CA p.H1047R);alpelisib(PIK3CA p.R88Q);Sonidegib,Vismodegib(PTCH1 p.P1202Lfs*53)","Level 3B",1
"Neratinib(ERBB2 p.V842I)","Level 3B",1
"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib(NRAS p.Q61K);alpelisib(PIK3CA p.N345K)","Level 3B",1
"AZD5363(AKT1 p.E17K);Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib(NRAS p.Q61K)","Level 3B",1
"AG-120(IDH1 p.R132C)","Level 3B",2
"Entrectinib(NTRK1 LEVEL_3A)","Level 3B",4
"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib(NRAS p.Q61K);Cobimetinib,Trametinib,Selumetinib(MAP2K1 p.G128V)","Level 3B",1
"alpelisib(PIK3CA p.G106_R108del)","Level 3B",1
"alpelisib(PIK3CA p.R38H);Sonidegib,Vismodegib(PTCH1 p.C454Ffs*2)","Level 3B",1
"Cobimetinib,Trametinib,Selumetinib(MAP2K1 p.E102_I103del);Cobimetinib,Trametinib,Selumetinib(MAP2K1 p.E102_I103del)","Level 3B",1
"alpelisib(PIK3CA p.G118D)","Level 3B",2
"alpelisib(PIK3CA p.R88Q)","Level 3B",2
"alpelisib(PIK3CA p.R108H)","Level 3B",2
"alpelisib(PIK3CA p.E453K)","Level 3B",1
"Cobimetinib,Trametinib,Selumetinib(MAP2K1 p.Y130C)","Level 3B",1
"Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52)","Level 3B",1
"alpelisib(PIK3CA p.R38H);Capmatinib,Cabozatinib(MET p.X1087_splice)","Level 3B",1
"Neratinib(ERBB2 p.V777L)","Level 3B",1
"alpelisib(PIK3CA p.G106R)","Level 3B",1
"alpelisib(PIK3CA p.H1047R);alpelisib(PIK3CA p.Q546R)","Level 3B",1
"AG-221(IDH2 p.R172K)","Level 3B",1
"alpelisib(PIK3CA p.Q546R)","Level 3B",1
"alpelisib(PIK3CA p.E545K);Trametinib(BRAF p.K601E)","Level 3B",1
"alpelisib(PIK3CA p.C378R)","Level 3B",1
"alpelisib(PIK3CA p.E542K);AG-221(IDH2 p.R172K)","Level 3B",1
"Neratinib(ERBB2 p.D769Y)","Level 3B",1
